NANDANEE MYNENI: Open Payments
NPI 1487872131 · ELIZABETH, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,129 in 62 payments from 19 companies in 2025. Trend: 2023 $1,722 · 2024 $1,447 · 2025 $1,129
Food & beverage: $1,129
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $162 |
| Corcept Therapeutics | 9 | $144 |
| Novo Nordisk Inc | 9 | $140 |
| Lilly USA, LLC | 6 | $102 |
| Ardelyx, Inc. | 4 | $74 |
| GlaxoSmithKline, LLC. | 4 | $72 |
| Novartis Pharmaceuticals Corporation | 3 | $58 |
| Exact Sciences Corporation | 3 | $52 |
| ABBVIE INC. | 3 | $51 |
| PFIZER INC. | 3 | $49 |
Products named: Korlym, MOUNJARO, IBSRELA, TRELEGY ELLIPTA, Ozempic, JARDIANCE, LEQVIO, REXULTI.
Industry payments across NJ — which companies pay providers there.
